Publication | Open Access
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast Cancer
148
Citations
23
References
2020
Year
ClinicalTrials.gov Identifier: NCT03051659.
| Year | Citations | |
|---|---|---|
Page 1
Page 1